On Tuesday, October 20, Usana Health Sciences USNA will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Earnings and Revenue
Analysts predict Usana Health Sciences will report earnings of $1.25 per share on revenue of $277.26 million. Usana Health Sciences earnings in the same period a year ago was $1.09 per share. Quarterly sales came in at $260.60 million. If the company were to report earnings in line when it publishes results Tuesday, quarterly profit would be up 14.68%. Revenue would be have grown 6.39% from the same quarter last year. Here is how the Usana Health Sciences's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q2 2020 | Q1 2020 | Q4 2020 | Q3 2019 |
|---|---|---|---|---|
| EPS Estimate | 1.10 | 0.83 | 0.98 | 0.86 |
| EPS Actual | 1.32 | 1.23 | 1.41 | 1.09 |
| Revenue Estimate | 264.15 M | 240.68 M | 252.75 M | 261.24 M |
| Revenue Actual | 258.99 M | 266.62 M | 271.30 M | 260.60 M |
Stock Performance
Shares of Usana Health Sciences were trading at $77.22 as of October 16. Over the last 52-week period, shares are up 7.08%. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. Usana Health Sciences is scheduled to hold the call at 11:00:00 ET and can be accessed here: https://78449.themediaframe.com/dataconf/productusers/usana/mediaframe/39319/indexl.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
